Chinese Journal of Dermatology ›› 2019, Vol. 52 ›› Issue (9): 593-597.doi: 10.3760/cma.j.issn.0412-4030.2019.09.001
• Expert Commentary • Previous Articles Next Articles
Li Chunying, Li Shuli
Received:
2018-09-04
Revised:
2019-03-24
Online:
2019-09-15
Published:
2019-08-30
Contact:
Li Chunying
E-mail:lichying@fmmu.edu.cn
Supported by:
Li Chunying, Li Shuli. Pathogenesis of vitiligo[J].Chinese Journal of Dermatology, 2019, 52(9): 593-597.
[1] | Denat L, Kadekaro AL, Marrot L, et al. Melanocytes as instigators and victims of oxidative stress[J]. J Invest Dermatol, 2014,134(6):1512⁃1518. doi: 10.1038/jid.2014.65. |
[2] | Yuksel EP, Aydin F, Senturk N, et al. Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase⁃superoxide dismutase treatment in vitiligo patients[J]. Eur J Dermatol, 2009,19(4):341⁃344. doi: 10.1684/ejd.2009.0699. |
[3] | He Y, Li S, Zhang W, et al. Dysregulated autophagy increased melanocyte sensitivity to H2O2⁃induced oxidative stress in vitiligo[J]. Sci Rep, 2017,7:42394. doi: 10.1038/srep42394. |
[4] | Jian Z, Li K, Song P, et al. Impaired activation of the Nrf2⁃ARE signaling pathway undermines H2O2⁃induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo[J]. J Invest Dermatol, 2014,134(8):2221⁃2230. doi: 10.1038/jid.2014.152. |
[5] | Jian Z, Tang L, Yi X, et al. Aspirin induces Nrf2⁃mediated transcriptional activation of haem oxygenase⁃1 in protection of human melanocytes from H2O2⁃induced oxidative stress[J]. J Cell Mol Med, 2016,20(7):1307⁃1318. doi: 10.1111/jcmm.12812. |
[6] | Chang Y, Li S, Guo W, et al. Simvastatin protects human melanocytes from H2O2⁃induced oxidative stress by activating Nrf2[J]. J Invest Dermatol, 2017,137(6):1286⁃1296. doi: 10. 1016/j.jid.2017.01.020. |
[7] | Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus[J]. Br J Dermatol, 2013,168(1):5⁃19. doi: 10.1111/j.1365⁃2133.2012. 11197.x. |
[8] | van den Boorn JG, Konijnenberg D, Dellemijn TA, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients[J]. J Invest Dermatol, 2009,129(9):2220⁃2232. doi: 10.1038/jid.2009.32. |
[9] | Cheuk S, Schlums H, Gallais Sérézal I, et al. CD49a expression defines tissue⁃resident CD8+ T cells poised for cytotoxic function in human skin[J]. Immunity, 2017,46(2):287⁃300. doi: 10.1016/j.immuni.2017.01.009. |
[10] | Richmond JM, Strassner JP, Zapata L Jr, et al. Antibody blockade of IL⁃15 signaling has the potential to durably reverse vitiligo[J]. Sci Transl Med, 2018,10(450). pii: eaam7710. doi: 10.1126/ scitranslmed.aam7710. |
[11] | Rashighi M, Agarwal P, Richmond JM, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo[J]. Sci Transl Med, 2014,6(223):223ra23. doi: 10.1126/scitranslmed.3007811. |
[12] | Wang XX, Wang QQ, Wu JQ, et al. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo[J]. Br J Dermatol, 2016,174(6):1318⁃1326. doi: 10.1111/bjd.14416. |
[13] | Li S, Zhu G, Yang Y, et al. Oxidative stress drives CD8+ T⁃cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes[J]. J Allergy Clin Immunol, 2017,140(1):177⁃189.e9. doi: 10.1016/j.jaci.2016.10.013. |
[14] | Rashighi M, Harris JE. Interfering with the IFN⁃γ/CXCL10 pathway to develop new targeted treatments for vitiligo[J]. Ann Transl Med, 2015,3(21):343. doi: 10.3978/j.issn.2305⁃5839.2015. 11.36. |
[15] | Craiglow BG, King BA. Tofacitinib citrate for the treatment of vitiligo: a pathogenesis⁃directed therapy[J]. JAMA Dermatol, 2015,151(10):1110⁃1112. doi: 10.1001/jamadermatol.2015.1520. |
[16] | Harris JE, Rashighi M, Nguyen N, et al. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)[J]. J Am Acad Dermatol, 2016,74(2):370⁃371. doi: 10.1016/j.jaad.2015.09.073. |
[17] | Rothstein B, Joshipura D, Saraiya A, et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib[J]. J Am Acad Dermatol, 2017,76(6):1054⁃1060.e1. doi: 10.1016/j.jaad.2017. 02.049. |
[18] | Joshipura D, Alomran A, Zancanaro P, et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: a 32⁃week open⁃label extension study with optional narrow⁃band ultraviolet B[J]. J Am Acad Dermatol, 2018,78(6):1205⁃1207.e1. doi: 10. 1016/j.jaad.2018.02.023. |
[19] | Liu LY, Strassner JP, Refat MA, et al. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure[J]. J Am Acad Dermatol, 2017,77(4):675⁃682.e1. doi: 10.1016/j.jaad.2017.05.043. |
[20] | Rezk AF, Kemp DM, El⁃Domyati M, et al. Misbalanced CXCL12 and CCL5 chemotactic signals in vitiligo onset and progression[J]. J Invest Dermatol, 2017,137(5):1126⁃1134. doi: 10.1016/j.jid.2016.12.028. |
[21] | Chatterjee S, Eby JM, Al⁃Khami AA, et al. A quantitative increase in regulatory T cells controls development of vitiligo[J]. J Invest Dermatol, 2014,134(5):1285⁃1294. doi: 10.1038/jid.2013.540. |
[22] | Eby JM, Kang HK, Tully ST, et al. CCL22 to activate treg migration and suppress depigmentation in vitiligo[J]. J Invest Dermatol, 2015,135(6):1574⁃1580. doi: 10.1038/jid.2015.26. |
[23] | Mosenson JA, Zloza A, Klarquist J, et al. HSP70i is a critical component of the immune response leading to vitiligo[J]. Pigment Cell Melanoma Res, 2012,25(1):88⁃98. doi: 10.1111/j.1755⁃148X.2011.00916.x. |
[24] | Mosenson JA, Zloza A, Nieland JD, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo[J]. Sci Transl Med, 2013,5(174):174ra28. doi: 10.1126/scitranslmed.3005127. |
[25] | Henning SW, Fernandez MF, Mahon JP, et al. HSP70iQ435A⁃encoding dna repigments vitiligo lesions in sinclair swine[J]. J Invest Dermatol, 2018,138(12):2531⁃2539. doi: 10.1016/j.jid.2018.06.186. |
[26] | Zhang Y, Liu L, Jin L, et al. Oxidative stress⁃induced calreticulin expression and translocation: new insights into the destruction of melanocytes[J]. J Invest Dermatol, 2014,134(1):183⁃191. doi: 10.1038/jid.2013.268. |
[27] | Levandowski CB, Mailloux CM, Ferrara TM, et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin⁃1β processing via the NLRP1 inflammasome[J].Proc Natl Acad Sci U S A, 2013,110(8):2952⁃2956. doi: 10.1073/pnas.1222808110. |
[28] | Shi Q, Zhang W, Guo S, et al. Oxidative stress⁃induced overexpression of miR⁃25: the mechanism underlying the degeneration of melanocytes in vitiligo[J]. Cell Death Differ, 2016,23(3):496⁃508. doi: 10.1038/cdd.2015.117. |
[29] | Richmond JM, Bangari DS, Essien KI, et al. Keratinocyte⁃derived chemokines orchestrate T⁃cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease[J]. J Invest Dermatol, 2017,137(2):350⁃358. doi: 10.1016/j.jid.2016.09.016. |
[30] | Li S, Zhu G, Yang Y, et al. Oxidative stress⁃induced chemokine production mediates CD8(+) T cell skin trafficking in vitiligo[J]. J Investig Dermatol Symp Proc, 2015,17(1):32⁃33. doi: 10.1038/jidsymp.2015.8. |
[31] | Regazzetti C, Joly F, Marty C, et al. Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients[J]. J Invest Dermatol, 2015,135(12):3105⁃3114. doi: 10.1038/jid.2015.335. |
[1] | Jin Rong, Hong Weisong, Xu Ai’e. Autologous cultured melanocyte transplantation for the treatment of genital vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(6): 429-430. |
[2] | Cai Yutian, Guo Ningning, Guo Yuan, Wang Luyuan, Liu Liping, Li Yumei . Effect of latanoprost on cell proliferation of and melanogenesis in human epidermal melanocytes and its mechanism [J]. Chinese Journal of Dermatology, 2019, 52(6): 408-413. |
[3] | Shi Jiaqi, Li Xue, Sun Li, Zhao Wen′e, Ding Shuhong, Hou Xiaoyuan, Xiu Yanyan, Lu Yan. In vitro effect of low-concentration hydrogen peroxide on autophagy in human melanocytes and screening for autophagy-related lncRNAs [J]. Chinese Journal of Dermatology, 2019, 52(6): 383-388. |
[4] | Chen Xuguang, Ma Jinyuan, Zhang Yuwei, Guo Yanyang, Liu Ling, Li Chunying. Application of dermoscopy in the diagnosis and differential diagnosis of vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(6): 425-428. |
[5] | Hou Xiaoyuan, Lu Yan. Application of platelet-rich plasma in dermatology [J]. Chinese Journal of Dermatology, 2019, 52(4): 279-282. |
[6] | Zhang Shaolong, Chang Yuqian, Lin Xingxiao, Su Xin, Jian Zhe, Li Chunying. Application of camouflage therapy in vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 283-285. |
[7] | Lei Jiehao, Fan Qimin, Chen Rong, Xu Ai′e. Association between efficacy of and response to narrow-band ultraviolet B phototherapy as well as factors related to phototherapy response in patients with vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 259-262. |
[8] | Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161. |
[9] | Yuan Guo Yu-Tian Cai Ning-Ning Guo. Expression of nucleobindin 2-encoded satiety and fat-influencing protein-1 and interleukin-26 in the serum of patients with vitiligo and its significance [J]. Chinese Journal of Dermatology, 2019, 52(2): 94-99. |
[10] | Chen Rong, Xu Ai′e. Morphological analysis of melasma lesions at different clinical stages by using three different skin imaging techniques [J]. Chinese Journal of Dermatology, 2019, 52(2): 103-106. |
[11] | Chen Rong, Lei Jiehao, Xu Ai′e. Efficacy of Q-switched Nd:YAG laser in the treatment of melasma in female patients and analysis of factors influencing the efficacy [J]. Chinese Journal of Dermatology, 2019, 0(0): 20180803-20180803. |
[12] | Huang Yuanbo, Yang Jun, Wang Lei, Li Zhongming, Zhang Lichao, Guo Xianfei, Sun Jie, Zhu Jing, Zhu Qilin, Bi Mingye. Dermoscopic features of blue nevi [J]. Chinese Journal of Dermatology, 2019, 0(0): 20190256-20190256. |
[13] | Wang-Min Qing-wei Geng Ya-li Gao You Song XiuZu. Effect of narrow-band ultraviolet B radiation on the autophagy of cultured human melanocytes in vitro [J]. Chinese Journal of Dermatology, 2018, 51(9): 665-669. |
[14] | Ming LI jianmin chang. Clinical scoring systems of vitiligo [J]. Chinese Journal of Dermatology, 2018, 51(6): 478-479. |
[15] | . Efficacy of 308-nm excimer laser versus high-intensity ultraviolet radiation for the treatment of active localized vitiligo [J]. Chinese Journal of Dermatology, 2018, 51(6): 413-416. |
|